Details for 2014733889

Up to date per 04.04.2026

Actions

Title / Product Name

VERFAHREN ZUR REDUZIERUNG VON RESTLICHEM CHOLESTERIN UND ANDEREN LIPOPROTEINFRAKTIONEN DURCH VERABREICHUNG EINES INHIBITORS VON PROPROTEIN-KONVERTASE-SUBTILISIN-KEXIN-9 (PCSK9)

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2014733889

EP Publication Number

3003361

E-Number

1150168

Language

PCT Number

US14040163

Publication Date

13.04.2016 A

03.07.2019 B1

Registration Date

03.07.2019

AT Publication Date

15.07.2019

Application Date

30.05.2014

Registration Number

Priorities

30.05.2013

201361828753 P

08.11.2013

201361901705 P

23.12.2013

201361919836 P

04.02.2014

201461935358 P

17.03.2014

201461953959 P

12.05.2014

201461991738 P

29.05.2014

201414290544

IPC

A61K 39/00 20060101AFI20170831BHEP

Maximum Duration of Protection

30.05.2034

Owner

Regeneron Pharmaceuticals, Inc.777 Old Saw Mill River Road Tarrytown, NY 10591US

Representative

No representatives present

Inventor

SWERGOLD, Gary75 Sheldrake Place New Rochelle, NY 10804US

SASIELA, William, J.c/o Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown, NY 10591-6706US

PORDY, Robert, C.c/o Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown, NY 10591-6706US